SHAREHOLDER ALERT: Pomerantz LLP Investigates Claims That the Merger May Not Be in the Best Interest of Investors of Polypore International, Inc. - PPO
NEW YORK, Feb. 23, 2015 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Polypore International, Inc. ("Polypore" or the "Company") (NYSE: PPO) (CUSIP: 73179V103) concerning the proposed acquisition of Polypore by Asahi Kasei Corporation.
Polypore shareholders seeking more information about this acquisition are advised to contact Robert Willoughby at [email protected] or 212-661-1100 or 888-476-6529, ext. 237.
The investigation concerns whether the Polypore directors are breaching their fiduciary duties by failing to adequately shop the Company and maximize shareholder value. Under the terms of the proposed acquisition, shareholders of Polypore will receive $60.50 per share of Polypore common stock. However, an analyst recently set a price target of $62.00 per share of Polypore common stock.
Pomerantz LLP, with offices in New York, Chicago, Florida, and San Diego, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz LLP pioneered the field of securities class actions. Today, more than 75 years later, the Pomerantz LLP continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of defrauded investors. See www.pomerantzlaw.com.
CONTACT:
Robert Willoughby
Pomerantz LLP
212-661-1100 ext. 237
[email protected]
SOURCE Pomerantz LLP
Share this article